Healthpeak Properties Sells Brookfield Minority Stake in $2.1 Billion Portfolio
By Dean Seal
Real estate investment trust Healthpeak Properties is selling to Brookfield Asset management a 49% stake in a $2.1 billion portfolio of outpatient medical buildings in the U.S.
The companies said Monday that the long-term strategic capital partnership will see Healthpeak continue managing the portfolio of properties, in which it retains a 51% stake, while receiving gross proceeds of $1.025 billion from the sale of its 49% interest.
The deal provides Healthpeak with long-term capital while preserving its operational control of the portfolio.
Healthpeak has an option to buy back the stake from Brookfield in seven years at a price that guarantees Brookfield a 6.5% annual return on its investment.
The portfolio consists of 86 properties with about 5.6 million square feet across 11 states, including Kentucky, Indiana, Pennsylvania, Arkansas, Illinois, Minnesota, New Jersey and New York. The properties are 95% leased, with a weighed average remaining lease term of six years.
Write to Dean Seal at dean.seal@wsj.com
(END) Dow Jones Newswires
July 20, 2026 08:00 ET (12:00 GMT)
Copyright (c) 2026 Dow Jones & Company, Inc.The articles, information, and content displayed on this webpage may include materials prepared and provided by third parties. Such third-party content is offered for informational purposes only and is not endorsed, reviewed, or verified by Morningstar.
Morningstar makes no representations or warranties regarding the accuracy, completeness, timeliness, or reliability of any third-party content displayed on this site. The views and opinions expressed in third-party content are those of the respective authors and do not necessarily reflect the views of Morningstar, its affiliates, or employees.
Morningstar is not responsible for any errors, omissions, or delays in this content, nor for any actions taken in reliance thereon. Users are advised to exercise their own judgment and seek independent financial advice before making any decisions based on such content. The third-party providers of this content are not affiliated with Morningstar, and their inclusion on this site does not imply any form of partnership, agency, or endorsement.
Popular
4 Stocks to Buy Before They Rise Further
2 Undervalued Stocks to Buy Before They Rebound
The 10 Best Companies to Invest in Now
The 10 Best Dividend Stocks
United States